WebDisclosure WebDisclosure
Basculer en Français
9551 Companies
188497 Keywords
120329 Articles
100651 Press releases
Headlines Articles Press releases MTS US Remove
  1. Home
  2. Companies
  3. MTS US
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 08/05/2024 at 16:05, 1 year 4 months ago

    Innovative Breakthroughs in Aesthetic Medicine: Dr. Maria Fedchuk’s Contributions

    Aesthetic Medicine Innovative Treatments FDA Approved Exosomal Liquid Laser Dr. Maria Fedchuk
  • BRIEF

    published on 08/05/2024 at 16:05, 1 year 4 months ago

    Percées innovantes en médecine esthétique : contributions du Dr Maria Fedchuk

    Médecine Esthétique Traitements Innovants Approuvé Par La FDA Laser Liquide Exosomal Dr Maria Fedchuk
  • PRESS RELEASE

    published on 08/05/2024 at 16:00, 1 year 4 months ago

    Transforming Aesthetics: Dr. Maria Fedchuk's Journey of Innovation at MTS US

    The 22nd Aesthetic & Anti-Aging Medicine World Congress unveils groundbreaking EXOSOMAL LIQUID LASER and award-winning RADIANCE by PEELING SYSTEM. Dr. Maria Fedchuk leads innovation in the aesthetic industry
    Aesthetic Medicine Exosomal Liquid Laser Dr. Maria Fedchuk RADIANCE MTS US
    Logo of MTS US
Accesswire
  • Published on 12/18/2025 at 22:45, 20 minutes ago

    Stabilis Solutions Announces Multi-Year Marine Bunkering Agreement with Carnival Coprporation at Proposed Galveston LNG Liquefaction Facility

  • Published on 12/18/2025 at 20:50, 2 hours 15 minutes ago

    Results of AGM

  • Published on 12/18/2025 at 18:00, 5 hours 5 minutes ago

    PPX Mining Announces 2025 AGM Results

  • Published on 12/18/2025 at 15:00, 8 hours 5 minutes ago

    Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia

  • Published on 12/18/2025 at 14:31, 8 hours 34 minutes ago

    Worksport Reports Highest Monthly Revenue in Company History

View all ACCESSWIRE
EQS Group
  • Published on 12/18/2025 at 22:05, 1 hour ago

    Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology

  • Published on 12/18/2025 at 22:05, 1 hour ago

    Abivax to be Added to Nasdaq Biotechnology Index

  • Published on 12/18/2025 at 20:09, 2 hours 56 minutes ago

    EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond

  • Published on 12/18/2025 at 19:30, 3 hours 35 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT

  • Published on 12/18/2025 at 19:30, 3 hours 35 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST

View all EQS
Les Echos
  • Published on 12/18/2025 at 18:30, 4 hours 35 minutes ago

    Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

  • Published on 12/18/2025 at 18:30, 4 hours 35 minutes ago

    Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde

  • Published on 12/18/2025 at 17:45, 5 hours 20 minutes ago

    Cie du Bois Sauvage: Vernietiging eigen aandelen

  • Published on 12/18/2025 at 17:45, 5 hours 20 minutes ago

    Damartex réaffirme son éligibilité au PEA-PME

  • Published on 12/18/2025 at 17:45, 5 hours 20 minutes ago

    Cie du Bois Sauvage : Cancellation of own shares

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy